BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18951882)

  • 1. (-)-Catechin promotes adipocyte differentiation in human bone marrow mesenchymal stem cells through PPAR gamma transactivation.
    Shin DW; Kim SN; Lee SM; Lee W; Song MJ; Park SM; Lee TR; Baik JH; Kim HK; Hong JH; Noh M
    Biochem Pharmacol; 2009 Jan; 77(1):125-33. PubMed ID: 18951882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (-)-Catechin suppresses expression of Kruppel-like factor 7 and increases expression and secretion of adiponectin protein in 3T3-L1 cells.
    Cho SY; Park PJ; Shin HJ; Kim YK; Shin DW; Shin ES; Lee HH; Lee BG; Baik JH; Lee TR
    Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1166-72. PubMed ID: 17164435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hedgehog signaling alters adipocyte maturation of human mesenchymal stem cells.
    Fontaine C; Cousin W; Plaisant M; Dani C; Peraldi P
    Stem Cells; 2008 Apr; 26(4):1037-46. PubMed ID: 18258719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased adipogenesis of osteoporotic human-mesenchymal stem cells (MSCs) characterizes by impaired leptin action.
    Astudillo P; Ríos S; Pastenes L; Pino AM; Rodríguez JP
    J Cell Biochem; 2008 Mar; 103(4):1054-65. PubMed ID: 17973271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin regulates osteoblast and adipocyte differentiation of rat mesenchymal stem cells.
    Gao Y; Xue J; Li X; Jia Y; Hu J
    J Pharm Pharmacol; 2008 Dec; 60(12):1695-700. PubMed ID: 19000376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteogenic growth peptide C-terminal pentapeptide [OGP(10-14)] acts on rat bone marrow mesenchymal stem cells to promote differentiation to osteoblasts and to inhibit differentiation to adipocytes.
    Chen ZX; Chang M; Peng YL; Zhao L; Zhan YR; Wang LJ; Wang R
    Regul Pept; 2007 Jul; 142(1-2):16-23. PubMed ID: 17331598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of GATA-2 and overexpression of adipogenic gene-PPARgamma in mesenchymal stem cells from patients with aplastic anemia.
    Xu Y; Takahashi Y; Wang Y; Hama A; Nishio N; Muramatsu H; Tanaka M; Yoshida N; Villalobos IB; Yagasaki H; Kojima S
    Exp Hematol; 2009 Dec; 37(12):1393-9. PubMed ID: 19772889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipocyte differentiation in Sod2(-/-) and Sod2(+/+) murine bone marrow stromal cells is associated with low antioxidant pools.
    Lechpammer S; Epperly MW; Zhou S; Nie S; Glowacki J; Greenberger JS
    Exp Hematol; 2005 Oct; 33(10):1201-8. PubMed ID: 16219542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells.
    Bäckesjö CM; Li Y; Lindgren U; Haldosén LA
    Cells Tissues Organs; 2009; 189(1-4):93-7. PubMed ID: 18728353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-17A inhibits adipocyte differentiation in human mesenchymal stem cells and regulates pro-inflammatory responses in adipocytes.
    Shin JH; Shin DW; Noh M
    Biochem Pharmacol; 2009 Jun; 77(12):1835-44. PubMed ID: 19428338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic trioxide promotes senescence and regulates the balance of adipogenic and osteogenic differentiation in human mesenchymal stem cells.
    Cheng H; Qiu L; Zhang H; Cheng M; Li W; Zhao X; Liu K; Lei L; Ma J
    Acta Biochim Biophys Sin (Shanghai); 2011 Mar; 43(3):204-9. PubMed ID: 21257625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new concept underlying stem cell lineage skewing that explains the detrimental effects of thiazolidinediones on bone.
    Bruedigam C; Eijken M; Koedam M; van de Peppel J; Drabek K; Chiba H; van Leeuwen JP
    Stem Cells; 2010 May; 28(5):916-27. PubMed ID: 20213769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Increasing alcohol-induced osteogenesis of human bone marrow-derived mesenchymal cells using siRNA transient suppression of peroxisome proliferator activated receptor gamma: an in vitro experiment study].
    Zhang H; Cheng JQ; Huang Q; Yang J; Shen B; Zhou ZK; Kang PD; Lian YY; Pei FX
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(37):2603-8. PubMed ID: 19080706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydroxy-cholecalciferol stimulates adipocytic differentiation of porcine mesenchymal stem cells.
    Mahajan A; Stahl CH
    J Nutr Biochem; 2009 Jul; 20(7):512-20. PubMed ID: 18789667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood.
    Chang YJ; Shih DT; Tseng CP; Hsieh TB; Lee DC; Hwang SM
    Stem Cells; 2006 Mar; 24(3):679-85. PubMed ID: 16179428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow.
    Sanz C; Vázquez P; Blázquez C; Barrio PA; Alvarez Mdel M; Blázquez E
    Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E634-43. PubMed ID: 20040695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of pancreatic endocrine markers by prolactin-treated rat bone marrow mesenchymal stem cells.
    González P; Santos TM; Calil A; Corradi Perini C; Percegona LS; Silva IC; Kuligovski C; Aguiar AM; Câmara NO; Aita CA
    Transplant Proc; 2010 Mar; 42(2):566-9. PubMed ID: 20304194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells.
    Choi SS; Cha BY; Lee YS; Yonezawa T; Teruya T; Nagai K; Woo JT
    Life Sci; 2009 Jun; 84(25-26):908-14. PubMed ID: 19376135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAR-1622 is a selective peroxisome proliferator-activated receptor gamma partial activator with preserved antidiabetic efficacy and broader safety profile for fluid retention.
    Kim MK; Chae YN; Kim HS; Choi SH; Son MH; Kim SH; Kim JK; Moon HS; Park SK; Shin YA; Kim JG; Lee CH; Lim JI; Shin CY
    Arch Pharm Res; 2009 May; 32(5):721-7. PubMed ID: 19471887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.
    Kim MK; Chae YN; Son MH; Kim SH; Kim JK; Moon HS; Park CS; Bae MH; Kim E; Han T; Choi HH; Shin YA; Ahn BN; Lee CH; Lim JI; Shin CY
    Eur J Pharmacol; 2008 Oct; 595(1-3):119-25. PubMed ID: 18727927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.